$1.57
+0.19 (+13.77%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+2,370.1% upside
Low Target
$26.82
Average Target
$38.78
High Target
$44.92
Current Price
$1.57
Current
$1.57
$1.57
Target
$38.78
$38.78
$26.82
$38.78 avg
$44.92
Scenario Analysis
Bear Case
$26.82
1,608.3%
Low target
Base Case
$38.78
+2,370.1%
Avg target
Bull Case
$44.92
+2,761.1%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$6.99
-77.5% from high
52-Week Low
$0.95
+65.1% from low
Target vs 52W High
$38.78
+454.8% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +3.3% |
| AMGN | Hold | 43 | 49% | $190.87 | -54.0% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.1% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -13.3% |
| REGN | Buy | 37 | 70% | $76.80 | -90.4% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -53.9% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -43.8% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.4% |